Kevin Raymond Merrill Smith

Insider Reports History

Location
Marblehead, MA
Signature
/s/ Mary Wright, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Raymond Merrill Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
Inogen Inc CEO and President, Director Common Stock 133,462 $814,118 $6.10 01 Mar 2026 Direct
Inogen Inc CEO and President, Director Restricted Stock Unit 60,024 $550,237 $9.71 01 Mar 2026 Direct
Inogen Inc CEO and President, Director Restriced Stock Unit 90,000 27 Feb 2026 Direct
ONCOSEC MEDICAL Inc Director Stock Option (Right to Buy) 25,000 28 Jun 2021 Direct

Insider Reports Filed by Kevin Raymond Merrill Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INGN Inogen Inc 27 Feb 2026 10 -$267,790 4 CEO and President, Director 03 Mar 2026, 16:56
INGN Inogen Inc 01 Dec 2025 3 -$96,028 4 CEO and President, Director 02 Dec 2025, 16:06
INGN Inogen Inc 01 Sep 2025 1 +$11,985 4 CEO and President, Director 03 Sep 2025, 17:01
INGN Inogen Inc 28 Feb 2025 8 -$218,769 4 CEO and President, Director 04 Mar 2025, 18:41
INGN Inogen Inc 01 Dec 2024 3 -$133,794 4 CEO and President, Director 03 Dec 2024, 17:08
INGN Inogen Inc 01 Mar 2024 1 $0 4 CEO and President, Director 05 Mar 2024, 19:09
INGN Inogen Inc 10 Nov 2023 1 $0 4 CEO and President, Director 13 Nov 2023, 17:30
INGN Inogen Inc 10 Nov 2023 0 $0 3 CEO and President, Director 13 Nov 2023, 17:29
/report/000149315221015619-smith-kevin-raymond-merrill-2021-06-28 ONCOSEC MEDICAL Inc 28 Jun 2021 1 $0 4 Director 29 Jun 2021, 19:41